Internal Medicine, Endocrinology, Diabetes, & Metabolism · Valhalla, NY
NPI
1538308069
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
7
Medicare group memberships
Hospitals
3
Hospital affiliations
20 Hospital Oval West, Cedarwood Hall #322
Valhalla, NY, 10571
Phone (914) 493-1876
Groups this clinician bills Medicare through
Medicare paid, 2024
$183K
2,288 services
Medicare patients, 2024
618
Average age 54
Drug cost, 2024
$1.5M
5,722 prescriptions
Company payments, 2025
$49.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher R Palmeiro was code 99213 (office e&m - established), 1,542 times for 482 patients. In total Christopher R Palmeiro billed 2,288 services in 7 codes, and Medicare paid $183K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,542 | 482 | $77.71 | $120K |
| 99214 Office E&M - Established | Office | 563 | 275 | $98.20 | $55K |
| 99212 Office E&M - Established | Office | 151 | 141 | $25.61 | $3,867 |
| 99215 Office E&M - Established | Office | 19 | 18 | $125.90 | $2,392 |
By year: 2022 $160K for 2,066 services; 2023 $144K for 2,017 services; 2024 $183K for 2,288 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 29 | 23 | $2.97 | $86.19 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher R Palmeiro prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,119 prescriptions and refills. In total Christopher R Palmeiro wrote 5,722 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,119 | 1,141 | 106 | $12K |
| Metformin Hcl Generic | 892 | 900 | 82 | $8,034 |
| Atorvastatin Calcium Generic | 717 | 723 | 68 | $6,866 |
| Trulicity Dulaglutide | 320 | 320 | 25 | $333K |
| Rosuvastatin Calcium Generic | 278 | 286 | 26 | $7,270 |
| Pioglitazone Hcl Generic | 203 | 211 | 22 | $3,714 |
| Prolia Denosumab | 142 | 841 | 81 | $257K |
| Alendronate Sodium Generic | 140 | 143 | 15 | $8,942 |
| Teriparatide Generic | 99 | 105 | 15 | $259K |
| Metformin Hcl Er Metformin Hcl | 90 | 90 | Under 11 | $683 |
| Testosterone Cypionate Generic | 87 | 87 | Under 11 | $1,946 |
| Acarbose Generic | 86 | 86 | Under 11 | $2,910 |
| Bromocriptine Mesylate Generic | 82 | 82 | Under 11 | $34K |
| Testosterone Generic | 72 | 85 | Under 11 | $19K |
| Tradjenta Linagliptin | 70 | 70 | Under 11 | $39K |
Brand drugs: 1,441 claims; generic drugs: 4,081 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher R Palmeiro $49.99 ($49.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $49.99.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $49.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.